Cargando…

Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice

Idiopathic pulmonary fibrosis (IPF) is an incurable chronic progressive disease with a low survival rate and ineffective therapeutic options. We examined the effects of imrecoxib, a nonsteroidal anti-inflammatory drug, on experimental pulmonary fibrosis. The mouse IPF model was established by intrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Yang, Yang, Yue, Li, Xiaohe, Meng, Lingxin, Mao, Jiahe, Zhang, Jianwei, Gao, Jingjing, Yang, Cheng, Gu, Xiaoting, Zhou, Honggang, Zhang, Yanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663740/ https://www.ncbi.nlm.nih.gov/pubmed/38027732 http://dx.doi.org/10.1016/j.heliyon.2023.e20914

Ejemplares similares

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
por: Gu, Songtao, et al.
Publicado: (2023)

Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway
por: Li, Xiaohe, et al.
Publicado: (2023)

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023)

Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway
por: Li, Xiaohe, et al.
Publicado: (2021)

Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway
por: Ruan, Hao, et al.
Publicado: (2021)

Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway
por: Ruan, Hao, et al.
Publicado: (2021)

Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
por: Sun, Xueshan, et al.
Publicado: (2021)

Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-κB/Snail Signaling Pathway
por: Jin, Haihao
Publicado: (2020)

Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Liu, Wei, et al.
Publicado: (2013)

Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
por: Dong, Yingying, et al.
Publicado: (2015)

Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Tsai, Kuen-Daw, et al.
Publicado: (2011)

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
por: Huang, Jizhen, et al.
Publicado: (2020)

Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice
por: Song, Nana, et al.
Publicado: (2015)

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
por: Zeng, Qian, et al.
Publicado: (2023)

Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis
por: Zhou, Yan, et al.
Publicado: (2019)

Human Endometrial Regenerative Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Zhao, Yiming, et al.
Publicado: (2018)

Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats
por: HE, HUANYU, et al.
Publicado: (2015)

Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine
por: Tsukioka, Takuma, et al.
Publicado: (2017)

Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition
por: Liu, Yuan, et al.
Publicado: (2018)

Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis
por: Zhang, Zongmei, et al.
Publicado: (2015)

Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
por: Liu, Yani, et al.
Publicado: (2019)

Lack of bombesin receptor–activated protein attenuates bleomycin-induced pulmonary fibrosis in mice
por: Wang, Hui, et al.
Publicado: (2022)

Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2021)

Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021)

A Real-World Study on the Effect of Imrecoxib for Patients with Axial Spondyloarthritis
por: Zong, He-xiang, et al.
Publicado: (2022)

Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats
por: Tian, Sheng-Lan, et al.
Publicado: (2018)

Pulmonary fibrosis model of mice induced by different administration methods of bleomycin
por: Gul, Aman, et al.
Publicado: (2023)

Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis
por: Lan, Ying-Wei, et al.
Publicado: (2015)

Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo
por: Huang, Tsung-Teng, et al.
Publicado: (2015)

Prostaglandin D(2) Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis
por: Kida, Taiki, et al.
Publicado: (2016)

Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Arora, Aastha, et al.
Publicado: (2018)

MUTYH Deficiency Is Associated with Attenuated Pulmonary Fibrosis in a Bleomycin-Induced Model
por: Sun, Qingmin, et al.
Publicado: (2020)

3′5-Dimaleamylbenzoic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: González-García, Karina, et al.
Publicado: (2022)

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
por: Maghsadi, Zahra, et al.
Publicado: (2023)

Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation
por: Wang, Lan, et al.
Publicado: (2022)

Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Tong, Xiang, et al.
Publicado: (2021)

Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
por: Li, Xiaohe, et al.
Publicado: (2021)

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
por: Ishida, Yuko, et al.
Publicado: (2023)

Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects
por: Yang, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1625lb2e1fftvvqa0ltoa36rrq